로딩 중…
지수 로딩 중…
Jade Biosciences, Inc.
JBIO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$19.15-3.04%
2026-08-03
Financials
Valuation Metrics
Jade Biosciences, Inc.'s Market Cap is $945M. At end of 2025 it was $1.09B. Ranked #2524 of 3,112 in US market (top 81%), #1044 of 1,445 on NASDAQ (top 72%), #194 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 72%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $945M | US#2,524/3,112 Sec#194/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-130M | US—/3,112 Sec—/269 |
| Total Assets | $319M | US#2,881/3,112 Sec#203/269 |
| Net Assets | $296M | US#2,557/3,112 Sec#158/269 |
| Value | ||
| P/B | 3.19x | US#1,744/3,112 Sec#92/269 |
| FCF Yield | -12.33% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -43.72% | US#2,711/3,112 Sec#161/269 |
| ROA | -40.57% | US#2,929/3,112 Sec#194/269 |
| Financial Health | ||
| Debt Ratio | 7.75% | US#77/3,112 Sec#35/269 |
| Total Debt | $679000.00 | US#2,942/3,112 Sec#251/269 |
| FCF | $-117M | US#2,617/3,112 Sec#164/269 |
| Cash | $55M | US#2,539/3,112 Sec#220/269 |
| Current Ratio | 14.29x | US#167/3,112 Sec#53/269 |
| Performance | ||
| 1Y Return | 177.94% | US#143/3,112 Sec#48/269 |
| 1M Return | -10.97% | US#2,651/3,112 Sec#174/269 |
| From 52W High | -31.61% | US#2,235/3,112 Sec#169/269 |
| 1Y MDD | -44.21% | US#2,170/3,112 Sec#163/269 |
| Trading | ||
| Volume | 636,582 shares | US#1,882/3,112 Sec#185/269 |
| Trading Value | $12M | US#2,241/3,112 Sec#179/269 |
| Per Share | ||
| EPS | $-1.80 | US—/3,112 Sec—/269 |
| BPS | $4.70 | US#2,256/3,112 Sec#137/269 |